Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Aquestive Therapeutics, Inc. (AQST) had Tangible Shareholders Equity of $-72.59M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$10.00M |
|
$-13.55M |
|
$4.56M |
|
$5.44M |
|
$21.37M |
|
$-11.37M |
|
$-2.18M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-11.37M |
|
$-8.48M |
|
99.33M |
|
99.33M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$81.72M |
|
$3.86M |
|
$11.98M |
|
$93.70M |
|
$23.16M |
|
$31.84M |
|
$143.13M |
|
$166.29M |
|
$-72.59M |
|
|
Tangible Shareholders Equity |
$-72.59M |
$-72.59M |
|
99.35M |
|
| Cash Flow Statement Financials | |
$-31.31M |
|
$-0.24M |
|
$20.55M |
|
$71.55M |
|
$60.54M |
|
$-11.01M |
|
$3.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.53 |
|
-- |
|
-- |
|
-0.78 |
|
-0.44 |
|
54.40% |
|
-113.65% |
|
-113.65% |
|
-- |
|
-135.44% |
|
-135.44% |
|
$-31.56M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.56 |
|
0.84 |
|
106.74 |
|
18.66% |
|
18.66% |
|
-14.46% |
|
33.25% |
|
$-0.73 |
|
$-0.32 |
|
$-0.32 |
|